Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants:A phase III study (PNEU-PED-EU-2)

Authors :: Benfield, Thomas
Rämet, Mika
Valentini, Piero
Seppä, Ilkka
Dagan, Ron
Richmond, Peter
Mercer, Swati
Churchill, Clay
Lupinacci, Robert
McFetridge, Richard
Park, Jun
Wittke, Frederick
Banniettis, Natalie
Musey, Luwy
Bickham, Kara
Kaminski, Janusz
Benfield, Thomas
Rämet, Mika
Valentini, Piero
Seppä, Ilkka
Dagan, Ron
Richmond, Peter
Mercer, Swati
Churchill, Clay
Lupinacci, Robert
McFetridge, Richard
Park, Jun
Wittke, Frederick
Banniettis, Natalie
Musey, Luwy
Bickham, Kara
Kaminski, Janusz
Source :: Benfield , T , Rämet , M , Valentini , P , Seppä , I , Dagan , R , Richmond , P , Mercer , S , Churchill , C , Lupinacci , R , McFetridge , R , Park , J , Wittke , F , Banniettis , N , Musey , L , Bickham , K & Kaminski , J 2023 , ' Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants : A phase III study (PNEU-PED-EU-2) ' , Vaccine , vol. 41 , no. 15 , pp. 2456-2465 .
Publication Year :: 2023

Database :: OAIster
Journal :: Benfield , T , Rämet , M , Valentini , P , Seppä , I , Dagan , R , Richmond , P , Mercer , S , Churchill , C , Lupinacci , R , McFetridge , R , Park , J , Wittke , F , Banniettis , N , Musey , L , Bickham , K & Kaminski , J 2023 , ' Safety, tolerability, and immunogenicity of V114 pneumococcal vaccine compared with PCV13 in a 2+1 regimen in healthy infants : A phase III study (PNEU-PED-EU-2) ' , Vaccine , vol. 41 , no. 15 , pp. 2456-2465 .
Notes :: application/pdf, English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1478333665
Document Type :: Electronic Resource

Tools